Mitrix Bio leverages Right to Try laws and medical tourism for early human data on mitochondrial transplants, reflecting a biotech shift to reduce costs and speed innovation amid ethical debates. Mitr...
Recent studies uncover ATF5’s role in aging muscle, offering insights into sarcopenia but cautioning against direct targeting, with research pivoting to alternative strategies for improved muscl...
A recent study reveals that combining NMN and apigenin restores muscle and bone in aged mice, highlighting potential anti-aging therapies through NAD+ modulation. New research on NMN and apigenin offe...
ER-100 targets glaucoma and NAION through epigenetic reprogramming, with Phase II trials advancing, highlighting potential economic and healthcare disruptions in anti-aging therapies. Life Biosciences...
Recent studies reveal that aligning meal times with circadian rhythms can slow biological aging and improve metabolic health, offering non-pharmaceutical strategies for longevity. New research highlig...
Life Biosciences launches a Phase I trial for cellular reprogramming to treat age-related macular degeneration, challenging aging norms with FDA’s Plausible Mechanism Pathway, amid rising invest...
Research reveals vitamin C’s role in inhibiting ACSL4, reducing iron-driven oxidative damage and senescence in cynomolgus monkeys, positioning it as a promising geroprotective target for human h...
Exploring how mild mitochondrial stress through drugs like terbinafine and miglustat extends lifespan, with socioeconomic implications for longevity treatments. New research shows FDA-approved drugs c...
Recent research reveals how mitochondrial decline accelerates cellular senescence in blood vessels, driving conditions like atherosclerosis and blood-brain barrier leakage, with emerging therapies tar...
New research reveals Vitamin C delays aging by inhibiting ACSL4, reducing ferroptosis in cells and primates, with potential for human cognitive health improvements. A recent study shows Vitamin C targ...
